Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1390 JPD447Summary: JPD447 is a derivative of MAC-0547630. -
BA1391 Cymal-6Summary: Cymal-6 (Cyclohexyl-hexyl-β-D-maltoside) is a potent inhibitor. -
BA1392 NAG-thiazolineSummary: NAG-thiazoline is an inhibitor. -
BA1393 1-MonomyristinSummary: 1-Monomyristin was extracted from and inhibited hydrolysis of 2-oleoylglycerol (=32 μM) and fatty acid amide hydrolase (FAAH) activity (=18 μM). -
BA1394 CadrofloxacinSummary: Cadrofloxacin (Caderofloxacin; CS-940) is an orally active fluoroquinolone active molecule that is effective against aerobic/anaerobic Gram-positive and Gram-negative bacteria. -
BA1395 DATPTSummary: DATPT is a WLVSKF peptide mimetic molecule. -
BA1399 MorinidazoleSummary: Morinidazole is an orally effective 5-nitroimidazole antimicrobial agent that is metabolized in humans by N-glucuronidation and sulfonation. -
BA1400 AlpibectirSummary: An anti-bacterial agent. -
BA1401 AditoprimeSummary: Aditoprime (Aditoprim) is a selective bacterial dihydrofolate reductase inhibitor that inhibits the conversion of dihydrofolate to tetrahydrofolate. -
BA1402 GuaijaverinSummary: Guaijaverin is a urease inhibitor.

